Home
Search:
1146 feeds
357 categories
6113 articles (<24 hours)
16 registered users

Use the Mobile version
Mobile

Follow our Twitter feed

View our Linkpartners
Links

Username:
Password:

Register | Retrieve

Science


Valid HTML 4.01 Transitional

RSS FeedsWhat To Make Of AbbVie Buying Allergan
(WorldNews Health)

 
 

26 june 2019 15:08:23

 
What To Make Of AbbVie Buying Allergan
(WorldNews Health)
 




AbbVie (ABBV) has been under pressure for more than a year since it made an all-time high in January 2018. At the market close on Monday, before the market reaction on Tuesday from the announcement that ABBV was buying Allergan (AGN), ABBV was trading at $78 and change per share, a P/E of about 9.4, while AGN was trading $129 per share and change, a P/E of 7.8. If bought from the closing price on Monday, AGN would be a value investment for ABBV. Unfortunately, the market always requires the acquirer to pay a premium price. What`s The Actual Deal? Based on the market close price of ABBV of $78.45 on Monday, ABBV considered AGN for about $63 billion in a cash and stock deal. AGN shareholders...
 
17 viewsCategory: Science > Medicine
 
AbbVie Has It All: Growth, Dividend Growth And Compelling Valuation
(WorldNews Health)
Graduate Turns Obstacle into a Career in Nursing
(WorldNews Health)
 
 
blog comments powered by Disqus


Copyright © 2008 - 2019 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures Science Tweets Travel Photos Nachrichten Indigonet Finances Leer Mandarijn